Peptide Synthesis Market Size, Share, Trends, Industry Analysis Report: By Product, Technology, Application (Therapeutics, Diagnosis, and Research), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Marke

The global peptide synthesis market size is expected to reach USD 2,175.91 million by 2034, according to a new study by Polaris Market Research. The report “Peptide Synthesis Market Size, Share, Trends, Industry Analysis Report: By Product, Technology, Application (Therapeutics, Diagnosis, and Research), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Peptide synthesis is the chemical process of assembling amino acids in a specific sequence to create functional peptides used in pharmaceuticals, diagnostics, and research. One of the key peptide synthesis market trends is the increasing adoption of automated and high-throughput synthesis techniques, which improve production efficiency, scalability, and peptide purity. Automation has greatly reduced process variability and improved reproducibility, making peptide synthesis more reliable for large-scale manufacturing. Additionally, advancements in solid-phase and hybrid synthesis technologies have streamlined complex peptide production. Therefore, as the demand for high-quality synthetic peptides rises, continuous innovations in synthesis methodologies are expected to shape the future of the market.

Another trend impacting the peptide synthesis market development is the rising integration of peptide-based therapeutics in drug development pipelines, particularly for targeted and precision medicine applications. Peptides offer high specificity and reduced toxicity compared to traditional small molecules, making them ideal candidates for novel drug formulations. Pharmaceutical companies and research institutions are increasingly focusing on optimizing peptide stability, bioavailability, and delivery mechanisms to improve therapeutic efficacy. Furthermore, the growing interest in peptide-conjugate therapies, such as peptide-drug conjugates (PDCs) and peptide-nanoparticle formulations, is expanding the scope of peptide-based treatments. This trend is expected to drive further advancements in peptide synthesis technologies, driving the peptide synthesis market growth.

Peptide Synthesis Market Report Highlights

In terms of application, the therapeutics segment led the market in 2024, driven by the growing use of peptide-based drugs for treating diseases such as cancer, metabolic disorders, and autoimmune conditions.

Based on technology, the hybrid technology segment is anticipated to experience the fastest market growth as it integrates the benefits of both solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS).

North America accounted for the largest share of peptide synthesis market in 2024, supported by significant investments in pharmaceutical and biotechnology research and the presence of major peptide drug manufacturers and research institutions.

Asia Pacific is expected to see the fastest growth during the forecast period, fueled by increasing biotechnology investments, expanding pharmaceutical manufacturing capabilities, and rising demand for peptide-based therapeutics.

A few global key market players include Bachem Holding AG; Biotage; Creative Diagnostics; GenScript; Lonza; Merck KGaA; PolyPeptide Group; Puresynth Research Chemicals Pvt Ltd.; Syngene International Limited; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the peptide synthesis market report on the basis of product, technology, application, end use, and region:

By Product Outlook (Revenue, USD Million, 2020–2034)

Equipment

Reagents & Consumable

Services

By Technology Outlook (Revenue, USD Million, 2020–2034)

Solid Phase Peptide Synthesis (SPPS)

Liquid Phase Peptide Synthesis (LPPS)

Hybrid Technology

By Application Outlook (Revenue, USD Million, 2020–2034)

Therapeutics

Diagnosis

Research

By End Use Outlook (Revenue, USD Million, 2020–2034)

Pharmaceutical & Biotechnology Companies

Contract Development & Manufacturing Organization/Contract Research Organization

Academic & Research Institutes

By Regional Outlook (Revenue, USD Million, 2020–2034)

North America

• US
• Canada

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Vietnam
• Australia
• Rest of Asia Pacific

• Argentina
• Brazil
• Mexico
• Rest of Latin America

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa